| Assessment of omega-3 carboxylic acids in statin-treated patients with high levels of triglycerides and low levels of high-density lipoprotein cholesterol: Rationale and design of the STRENGTH trial |
55 |
| Effect of Vascepa (icosapent ethyl) on progression of coronary atherosclerosis in patients with elevated triglycerides (200-499 mg/dL) on statin therapy: Rationale and design of the EVAPORATE study |
27 |
| Sex differences in heart failure |
18 |
| Rationale and design of the Virginia Commonwealth University-Anakinra Remodeling Trial-3 (VCU-ART3): A randomized, placebo-controlled, double-blinded, multicenter study |
17 |
| Adverse pregnancy outcomes and future maternal cardiovascular disease |
12 |
| Why names matter for women: MINOCA/INOCA (myocardial infarction/ischemia and no obstructive coronary artery disease) |
11 |
| Hypertension in pregnancy: Taking cues from pathophysiology for clinical practice |
11 |
| Dysbiotic gut microbes may contribute to hypertension by limiting vitamin D production |
10 |
| Immediate clinical outcomes of left bundle branch area pacing vs conventional right ventricular pacing |
10 |
| Increasing incidence of IV-drug use associated endocarditis in southern West Virginia and potential economic impact |
10 |
| Does obesity affect the outcomes in takotsubo cardiomyopathy? Analysis of the Nationwide Inpatient Sample database, 2010-2014 |
10 |
| Consumption of a defined, plant-based diet reduces lipoprotein(a), inflammation, and other atherogenic lipoproteins and particles within 4 weeks |
10 |
| Lipid profile and incidence of atrial fibrillation: A prospective cohort study in China |
10 |
| Suspicious index in Lyme carditis: Systematic review and proposed new risk score |
9 |
| Association of galectin-3 with markers of myocardial function, atherosclerosis, and vascular fibrosis in patients with rheumatoid arthritis |
9 |
| Growth differentiation factor 15 is associated with left atrial/left atrial appendage thrombus in patients with nonvalvular atrial fibrillation |
9 |
| Low serum albumin: A significant predictor of reduced survival in patients with chronic heart failure |
9 |
| A clinical, proteomics, and artificial intelligence-driven model to predict acute kidney injury in patients undergoing coronary angiography |
9 |
| Anticoagulation in chronic kidney disease: from guidelines to clinical practice |
8 |
| Atrial remodeling and ectopic burden in recreational athletes: Implications for risk of atrial fibrillation |
8 |
| Interleukin-1 blockade treatment decreasing cardiovascular risk (Retracted article. See vol. pg. 2020) |
8 |
| Rationale, design and baseline characteristics of the effect of ticagrelor on health outcomes in diabetes mellitus patients Intervention study |
8 |
| Left atrial function in elite athletes: A meta-analysis of two-dimensional speckle tracking echocardiographic studies |
8 |
| Efficacy and safety of apixaban vs warfarin in patients with atrial fibrillation and prior bioprosthetic valve replacement or valve repair: Insights from the ARISTOTLE trial |
8 |
| The non-genetic paternal factors for congenital heart defects: A systematic review and meta-analysis |
7 |
| Efficacy and safety of short-term dual antiplatelet therapy (<= 6 months) after percutaneous coronary intervention for acute coronary syndrome: A systematic review and meta-analysis of randomized controlled trials |
7 |
| Advanced chronic kidney disease: Relationship to outcomes post-TAVR, a meta-analysis |
7 |
| A review of factors associated with maintenance of sinus rhythm after elective electrical cardioversion for atrial fibrillation |
7 |
| Atrial fibrillation patient preferences for oral anticoagulation and stroke knowledge: Results of a conjoint analysis |
7 |
| Impact of delirium on patients hospitalized for myocardial infarction: A propensity score analysis of the National Inpatient Sample |
6 |
| Spontaneous coronary artery dissection in women: What is known and what is yet to be understood |
6 |
| The connection between the breast and heart in a woman: Breast cancer and cardiovascular disease |
6 |
| Balloon pulmonary angioplasty vs riociguat in patients with inoperable chronic thromboembolic pulmonary hypertension: A systematic review and meta-analysis |
6 |
| Alcohol septal ablation vs myectomy for symptomatic hypertrophic obstructive cardiomyopathy: Systematic review and meta-analysis |
6 |
| Opportunities for improving use of evidence-based therapy in patients with type 2 diabetes and cardiovascular disease |
6 |
| Right atrial function by speckle tracking echocardiography in atrial septal defect: Prediction of atrial fibrillation |
6 |
| The prevalence of obstructive sleep apnea in patients with atrial fibrillation |
6 |
| Serum albumin concentration as an independent prognostic indicator in patients with pulmonary arterial hypertension |
6 |
| The evolving view of coronary artery calcium and cardiovascular disease risk |
6 |
| In-hospital outcomes comparison of transfemoral vs transapical transcatheter aortic valve replacement in propensity-matched cohorts with severe aortic stenosis |
6 |
| Use of Impella heart pump for management of women with peripartum cardiogenic shock |
5 |
| Elevated lipoprotein(a) and familial hypercholesterolemia in the coronary care unit: Between Scylla and Charybdis |
5 |
| Stem-cell therapy in ST-segment elevation myocardial infarction with reduced ejection fraction: A multicenter, double-blind randomized trial |
5 |
| Sex-related differences in left ventricular diastolic function and arterial elastance during admission in patients with heart failure with preserved ejection fraction: The PURSUIT HFpEF study |
5 |
| Association between ideal cardiovascular health and markers of subclinical cardiovascular disease |
5 |
| Electrocardiographic findings in peripartum cardiomyopathy |
5 |
| The role and outcome of cardiac rehabilitation program in patients with atrial fibrillation |
5 |
| Stroke prevention in patients from Latin American countries with non-valvular atrial fibrillation: Insights from the GARFIELD-AF registry |
5 |
| Interatrial block as a predictor of atrial fibrillation in patients with ST-segment elevation myocardial infarction |
5 |
| The emerging role of novel antihyperglycemic agents in the treatment of heart failure and diabetes: A focus on cardiorenal outcomes |
5 |
